• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AZIYO BIOLOGICS INC. PROXICOR FOR CARDIAC TISSUE REPAIR; PATCH, PLEDGET, INTRACARDIAC - DXZ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AZIYO BIOLOGICS INC. PROXICOR FOR CARDIAC TISSUE REPAIR; PATCH, PLEDGET, INTRACARDIAC - DXZ Back to Search Results
Model Number CMCV-120-401
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problems Aortic Valve Stenosis (1717); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Type  Injury  
Manufacturer Narrative
Manufacturing review of the proxicor for cardiac tissue repair device history record could not be performed.The lot/serial number is unknown.It is also noted that per the instructions for use (ifu - art-20700b) provided with the finished proxicor for cardiac tissue repair device, stenosis, patch dehiscence/rupture are listed as potential complications associated with the procedure and device.In addition, the ifu for the proxicor for cardiac tissue repair device provides a warning/precaution that the device must be sutured to viable native tissue.Indicating that all edges of sutured ecm patch be made to viable tissue which would exclude.Leaving a "free-edge" to simulate the commissural closure of the valve cusps.Further, in the suggested instructions for use (e.G.Implant) it is stated "7.Place the edge of proxicor in contact with viable tissue".Although the exact cause of the reported stenosis and patch prolapse (dehiscence/rupture) cannot be conclusively determined, these are known complications associated with the use of a proxicor for cardiac tissue repair and a surgical implant procedure.Should aziyo receive any additional details related to this event, a supplemental report will be filed.
 
Event Description
As part of the post market surveillance process, this article / clinical case report published in annals of thoracic surgery 2017;104:e431-3 titled "calcific degeneration of cormatrix 4 years after bicuspidization of unicuspid aortic valve" was reviewed.This article reports a case study related to a 12 year old boy with congenital aortic valve (av) stenosis treated with balloon valvuloplasty in infancy which had progressed to severe av stenosis.The patient underwent a bicuspidization procedure of a severely stenotic unicuspid aortic valve with cormatrix (now aziyo biologics) ecm for cardiac tissue repair (model #: cmcv-120-401, lot #: unknown) which upon completion of procedure demonstrated acceptable surgical and echocardiographic results.Patient evaluated every 3 months (1st year) and 6 months thereafter (2nd year) showing a stable and well-functioning aortic valve without any changes in leaflet size, integrity, function, or progression of postoperative mild insufficiency.At 52.5 months patient presented with progressive dyspnea.Echocardiography showed patch prolapse with severe aortic regurgitation, mild stenosis, and left ventricular dilatation.Reintervention was indicated, and the patient underwent a ross procedure.Attempts to contact corresponding author have been unsuccessful for any additional information.Should any additional information be received a follow-up report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROXICOR FOR CARDIAC TISSUE REPAIR
Type of Device
PATCH, PLEDGET, INTRACARDIAC - DXZ
Manufacturer (Section D)
AZIYO BIOLOGICS INC.
1100 old ellis road
ste 1200
roswell 30076
Manufacturer (Section G)
AZIYO BIOLOGICS INC.
1100 old ellis road
ste 1200
roswell GA 30076
Manufacturer Contact
michael hennick
1100 old ellis road
ste 1200
roswell 30076
4705144023
MDR Report Key10673565
MDR Text Key211335207
Report Number3005619880-2020-00048
Device Sequence Number1
Product Code DXZ
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
K063349
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature,study
Reporter Occupation Physician
Type of Report Initial
Report Date 10/13/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/13/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCMCV-120-401
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/08/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age14 YR
-
-